AbbVie Inc. reports $61.16 billion revenue for fiscal year ended December 31, 2025, up 8.6%
AbbVie Inc. reported revenue of $61.16 billion for the year ended December 31, 2025, an increase of 8.6% from the previous year ($56.33 billion).
For the same period it posted net income of $4.23 billion, down 1.2%, or $2.36 per diluted share (2.39 a year earlier).
That is a net margin of 6.9%.
On Sanad's AAOIFI Standard 21 screen, AbbVie Inc. is currently compliant: interest-bearing debt is 15.6% of market capitalisation (limit 30%), and impure income is 0.4% of revenue (limit 5%).
Is AbbVie Inc. halal?
See the full AAOIFI screening of AbbVie Inc.
See the full AAOIFI screening of AbbVie Inc.
Source: 10-K filed with the U.S. Securities and Exchange Commission on February 20, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.